Home
About
Team
Portfolio
News
Contact Us
2024-02-29
Tigermed-Jyton Announces Acquisition of NAMSA China and Global Strategic Partnership with NAMSA
Tigermed-Jyton’s acquisition of NAMSA China, as well as the exclusive China regional partnership and global collaboration
2024-02-26
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio
Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular
2024-01-02
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop
2023-11-06
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Ant
BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China
2023-10-12
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTec
MediLink announced that it has entered into a strategic research collaboration and worldwide license agreement with BioNTech SE
2023-06-12
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
Viva successfully raised nearly US$ 150 million through the transfer of approximately 24% of its equity interest to Temasek, HLC, and True Light.
1
2
3
4
5
25 records in total